Naive CLL
How did CLL lose its role of "Cinderella" in hematology in the last decades, thanks to the introduction of entirely new classes of drugs, and came under the spotlight of clinical research in hematology?
Prof Jennifer Woyach discusses the fundamentals of CLL genetics and treatment in this podcast, as well as the selection of patients for therapy, the different, and somewhat unpredictable, clinical course the disease can follow, together with the last evidence from CLL clinical trials.
Host: Prof Shaun McCann; Guest: Prof Jennifer Woyach
What did you think of this podcast? Share your opinions…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.